1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics, April 2016 (p31)

Healthcare Analysis & Statistics, April 2016 (p31)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

901-930 of about 36 000 reports

Purchase Reports From Reputable Market Research Publishers

Europe Glucose Monitoring Devices Industry 2016 Market Research Report

Europe Glucose Monitoring Devices Industry 2016 Market Research Report

  • $ 3 600
  • Industry report
  • April 2016
  • by QY Research Group

The Europe Glucose Monitoring Devices Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Glucose Monitoring Devices industry. The report provides a basic ...

  • Industries : Patient Monitoring Device
  • Countries : Europe
Global Negative Pressure Wound Therapy (NPWT) Devices Market Assessment & Forecast 2016 - 2020

Global Negative Pressure Wound Therapy (NPWT) Devices Market Assessment & Forecast 2016 - 2020

  • $ 3 500
  • Industry report
  • June 2016
  • by Spearhead Acuity

According to the new report “Global Negative Pressure Wound Therapy (NPWT) Devices Market Assessment & Forecast 2016 - 2020” by SA-Business Research & Consulting Group, North America continues to lead ...

  • Industries : Medical Supply
  • Countries : World
HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Competitive Strategies,  Country Market Segment Volume and Sales Forecasts

HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

Complete report $5,450. DataPack (test volumes, sales forecasts, supplier shares) $3,500. Summary This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, ...

  • Industries : Diagnostics
  • Countries : World
Hemostasis Testing: Leading Suppliers Strategic Profiles

Hemostasis Testing: Leading Suppliers Strategic Profiles

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

This 165-page report presents the clinical significance and market needs for major hemostasis laboratory tests, as well as extensive listings of companies developing or marketing innovative coagulation ...

  • Industries : In Vitro Diagnostics
US Diagnostics Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

US Diagnostics Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume ...

  • Industries : In Vitro Diagnostics, Blood Supply, Tissue Banking and Transplantation, Pathology, Healthcare
Pap Smear/Human Papillomavirus (HPV): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Pap Smear/Human Papillomavirus (HPV): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

  • Industries : In Vitro Diagnostics
CA Tumor Markers: CA 15-3/27.29, CA 19-9, CA 125--US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

CA Tumor Markers: CA 15-3/27.29, CA 19-9, CA 125--US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

  • Industries : Diagnostics
Coagulation Testing in Hospitals, Private Labs, and POC Locations--Supplier Shares, Country Volume and Sales Forecasts

Coagulation Testing in Hospitals, Private Labs, and POC Locations--Supplier Shares, Country Volume and Sales Forecasts

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

This report provides a worldwide overview of the coagulation testing market, including estimates of facilities performing coagulation tests, as well as test volume and sales forecasts for coagulation reagents ...

  • Industries : In Vitro Diagnostics
  • Countries : World
HIV/AIDS Diagnostics Market: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

HIV/AIDS Diagnostics Market: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology ...

  • Industries : In Vitro Diagnostics
  • Countries : Europe, Japan
CMV: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

CMV: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3 500
  • Industry report
  • June 2016
  • by Venture Planning Group

The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology ...

  • Industries : In Vitro Diagnostics
  • Countries : Europe, Japan
Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2015

Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2015

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Data

Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2015 Summary "GlobalData's “Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2015” report is an essential ...

  • Industries : Medical Device
  • Countries : World
Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016

Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Biopharmaceutical, Therapy, Cancer, OTC
  • Countries : United States
C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine ...

  • Industries : Biological Therapy
  • Countries : United States, World
Connexin (Gap Junction Protein) - Pipeline Review, H1 2016

Connexin (Gap Junction Protein) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

Connexin (Gap Junction Protein) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Connexin (Gap Junction Protein) - Pipeline Review, H1 2016’, provides in depth analysis on Connexin (Gap ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : World
C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine ...

  • Industries : Therapy, Biological Therapy
  • Countries : United States, World, Italy
Type-2 Angiotensin II Receptor (Angiotensin II Type-2 Receptor or AT2 or AGTR2) - Pipeline Review, H1 2016

Type-2 Angiotensin II Receptor (Angiotensin II Type-2 Receptor or AT2 or AGTR2) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

Type-2 Angiotensin II Receptor (Angiotensin II Type-2 Receptor or AT2 or AGTR2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Type-2 Angiotensin II Receptor (Angiotensin II Type-2 Recepto ...

  • Industries : Therapy, Chronic Disease, Pathology, Pharmaceutical
  • Countries : World
C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil ...

  • Industries : Biopharmaceutical, Chronic Disease, Biological Therapy, Pharmaceutical, Pathology
  • Countries : World
C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - ...

  • Industries : Biological Therapy, Therapy, Cancer, Pharmaceutical, Pathology
  • Countries : Japan, World
Eukaryotic Translation Initiation Factor 4E (eIF-4E) - Pipeline Review, H1 2016

Eukaryotic Translation Initiation Factor 4E (eIF-4E) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

Eukaryotic Translation Initiation Factor 4E (eIF-4E) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Eukaryotic Translation Initiation Factor 4E (eIF-4E) - Pipeline Review, H1 2016’, ...

  • Industries : Therapy, Cancer, Pathology, Drug Discovery and Development
  • Countries : United States, World
Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2016

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Interleukin-2 Receptor Subunit Alpha (IL-2 Receptor Subunit Alpha ...

  • Industries : Biopharmaceutical, Biological Therapy, Therapy, Biotechnology
  • Countries : World, United States
ATP Binding Cassette Sub Family A Member 1 (ATP Binding Cassette Transporter 1 or ABC 1 or ATP Binding Cassette 1 or Cholesterol Efflux Regulatory Protein or ABCA1) - Pipeline Review, H1 2016

ATP Binding Cassette Sub Family A Member 1 (ATP Binding Cassette Transporter 1 or ABC 1 or ATP Binding Cassette 1 or Cholesterol Efflux Regulatory Protein or ABCA1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • May 2016
  • by Global Markets Direct

ATP Binding Cassette Sub Family A Member 1 (ATP Binding Cassette Transporter 1 or ABC 1 or ATP Binding Cassette 1 or Cholesterol Efflux Regulatory Protein or ABCA1) - Pipeline Review, H1 2016 Summary Global ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Global Healthcare Virtual Reality & Augmented Reality Systems Market Assessment & Forecast: 2016 - 2020

Global Healthcare Virtual Reality & Augmented Reality Systems Market Assessment & Forecast: 2016 - 2020

  • $ 3 500
  • Industry report
  • May 2016
  • by Spearhead Acuity

According to the new report “Global Healthcare Virtual Reality & Augmented Reality Systems Market Assessment & Forecast: 2016 - 2020” by SA-Business Research & Consulting Group, global healthcare virtual ...

  • Countries : World
Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016

Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Steroid Hormone Receptor ERR1 (Estrogen Receptor-Like 1 or Estrogen-Related Receptor Alpha or ERR-Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or ESRRA or ERR1) - Pipeline Review, H1 2016

Steroid Hormone Receptor ERR1 (Estrogen Receptor-Like 1 or Estrogen-Related Receptor Alpha or ERR-Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or ESRRA or ERR1) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Steroid Hormone Receptor ERR1 (Estrogen Receptor-Like 1 or Estrogen-Related Receptor Alpha or ERR-Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or ESRRA or ERR1) - Pipeline Review, H1 2016 Summary ...

  • Industries : Therapy
  • Countries : World
Heparanase (Endo-Glucoronidase or Heparanase-1 or EC 3.2.1.166) - Pipeline Review, H1 2016

Heparanase (Endo-Glucoronidase or Heparanase-1 or EC 3.2.1.166) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Heparanase (Endo-Glucoronidase or Heparanase-1 or EC 3.2.1.166) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Heparanase (Endo-Glucoronidase or Heparanase-1 or EC 3.2.1.166) - Pipeline ...

  • Industries : Cancer, Pathology, Pharmaceutical, Therapy
  • Countries : World
Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or ALDOS or Aldosterone Synthesizing Enzyme or CYPXIB2 or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5) - Pipeline Review, H1 2016

Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or ALDOS or Aldosterone Synthesizing Enzyme or CYPXIB2 or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or ALDOS or Aldosterone Synthesizing Enzyme or CYPXIB2 or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 ...

  • Industries : Therapy
  • Countries : World
Peroxisome Proliferator-Activated Receptor Delta (PPAR-Delta or NUCI or Nuclear Hormone Receptor 1 or NUC1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator-Activated Receptor Beta or PPAR-Beta or PPARD or NR1C2) - Pipeline Revie

Peroxisome Proliferator-Activated Receptor Delta (PPAR-Delta or NUCI or Nuclear Hormone Receptor 1 or NUC1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator-Activated Receptor Beta or PPAR-Beta or PPARD or NR1C2) - Pipeline Revie

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Peroxisome Proliferator-Activated Receptor Delta (PPAR-Delta or NUCI or Nuclear Hormone Receptor 1 or NUC1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator-Activated Recepto ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World
Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor C or Retinoid-Related Orphan Receptor-Gamma or RORC) - Pipeline Review, H1 2016

Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor C or Retinoid-Related Orphan Receptor-Gamma or RORC) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor C or Retinoid-Related Orphan Receptor-Gamma or RORC) - Pipeline Review, ...

  • Industries : Pathology
  • Countries : United States, World
Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) - Pipeline Review, H1 2016

Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase ...

  • Industries : Therapy, Pharmaceutical, Chemical
  • Countries : United States
Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or CD10 or EC 3.4.24.11) - Pipeline Review, H1 2016

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or CD10 or EC 3.4.24.11) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or CD10 or EC 3.4.24.11) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Neprilysin ...

  • Industries : Chronic Disease, Therapy, Pathology, Pharmaceutical
  • Countries : World
About 108 000 reports

Download Unlimited Documents from Trusted Public Sources

Hospital Statistics in the US

  • June 2016
    51 pages
  • Hospital  

    Transportation  

    Housing  

  • United States  

View report >

Healthcare Markets

June 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.